leadf
logo-loader
viewCelavie Biosciences

Celavie Biosciences advancing its five year exploratory study in Parkinson's Disease

Celavie Biosciences CEO Sandy Solomon sat down with Proactive’s Christine Corrado at the BIO CEO & Investor Conference in New York. The California-based company is developing regenerative stem cell therapies to treat Parkinson’s disease and other central nervous system disorders.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

NexTech AR Solutions adds ticketing option for their 3D augmented reality...

NexTech AR Solutions (CSE: NTAR- OTCQB: NEXCF) CEO Evan Gappelberg joined Steve Darling from Proactive with news the company’s AirShow app, will have in-app purchases and ticketing capabilities beginning in early November. Gappelberg telling Proactive "our goal is to make creating AR human...

12 minutes ago

2 min read